Sino Biopharmaceutical Ltd (SBMFF)
OTHER OTC:SBMFF
Holding SBMFF?
Track your performance easily

Sino Biopharmaceutical (SBMFF) Financial Statements

28 Followers

Sino Biopharmaceutical Financial Overview

Sino Biopharmaceutical's market cap is currently ―. The company's EPS TTM is $0.018; its P/E ratio is 24.00; and it has a dividend yield of 1.69%. Sino Biopharmaceutical is scheduled to report earnings on March 28, 2025, and the estimated EPS forecast is
lt;0.01. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Dec 21Jun 21Dec 20Sep 20
Income Statement-
Total Revenue---¥ 5.52B¥ 5.48B
Gross Profit---¥ 4.41B¥ 4.20B
EBIT---¥ 1.33B¥ 1.22B
EBITDA---¥ 1.33B¥ 1.22B
Net Income Common Stockholders---¥ 920.59M¥ 609.88M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments¥ 15.67B¥ 15.79B¥ 10.44B¥ 16.43B¥ 18.53B
Total Assets¥ 64.93B¥ 60.54B¥ 56.21B¥ 47.21B¥ 66.20B
Total Debt¥ 12.02B¥ 12.12B¥ 13.65B¥ 14.21B¥ 14.28B
Net Debt¥ -3.66B¥ -3.68B¥ 3.21B¥ -2.22B¥ -4.25B
Total Liabilities-¥ 22.81B¥ 25.10B¥ 24.79B¥ 25.74B
Stockholders Equity¥ 30.21B¥ 30.29B¥ 24.58B¥ 16.75B¥ 31.67B
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in CNY

Sino Biopharmaceutical Earnings and Revenue History

Sino Biopharmaceutical Debt to Assets

Sino Biopharmaceutical Cash Flow

Sino Biopharmaceutical Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis